Manufacturing / Biological Products, Except Diagnostic Substances
Replimune Group, Inc.
REPL
$13.29
+$0.28 (+2.13%)
Price as of Oct 9, 2026 16:42 UTC
1.4 B
Market Cap (Small Cap)
6%
IV Rank
74.8%
Implied Volatility
Nov 04
Next Earnings
Technical Signals
as of Oct 7
Mixed
4 of 7
Trend
- Above 20-day average $13.27
- Above 50-day average $12.92
- Above 200-day average $10.01 · +31.9%
- Moving averages stacked 20 > 50 > 200
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) 88d ago
Volume
- Below-average volume 0.7x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
1.29
Bearish skew
Implied Volatility
74.8%
0% percentile
IV vs Realized
Options cheap
30d HV 219.3%
Options Heat Map
Delta-risk grid for REPL options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
2 buys
18 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Astley-Sparke Philip | Gift | 50,000 | $0 | -7.2% | |
| Aug 17, 2026 | Hill Emily Luisa | Sell | 9,256 | $132,176 | -8.7% | |
| Aug 11, 2026 | BAKER BROS. ADVISORS LP | Buy | 126,394 | $1,524,299 | +8.1% | |
| Aug 11, 2026 | BAKER BROS. ADVISORS LP | Buy | 2,609,946 | $31,475,688 | +8.1% | |
| Aug 10, 2026 | Schwendenman Andrew | Sell | 7,632 | $98,987 | +0.5% | |
| Aug 10, 2026 | Patel Sushil | Sell | 39,341 | $510,253 | +0.5% | |
| Aug 10, 2026 | Xynos Konstantinos | Sell | 11,447 | $148,468 | +0.5% | |
| Aug 10, 2026 | Hill Emily Luisa | Sell | 11,448 | $148,481 | +0.5% | |
| Jun 01, 2026 | Sarchi Christopher | Sell | 12,000 | $110,880 | +41.1% | |
| May 18, 2026 | Sarchi Christopher | Sell | 8,626 | $43,820 | +156.7% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 05, 2026 | Q1 2027 | -$0.70 |
Track REPL with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for REPL and your entire portfolio.